National Conference of the Italian Group for the Study of Neuromorphology
Vol. 70 No. s2 (2026): 36th National Conference of the Italian Group for the Study of...

OC26 | MORPHOLOGICAL ALTERATIONS UPON BORTEZOMIB-INDUCED NEUROTOXICITY IN HUMAN IPSC-DERIVED SCHWANN CELL PRECURSOR AND SENSORY NEURON MODELS

F. Iseppon1, E. Tonelli1, A. Malacrida1, V. Rodriguez-Menendez1, M. Santeusanio1, S. Palermo2, D. Cartelli3, A. Scuteri1, C. Meregalli1 | 1School of Medicine and Surgery, Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, Monza, Italy; 2Department of Biosciences, Università degli Studi di Milano, Italy; 3Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy

Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Published: 20 November 2026
0
Views
0
Downloads

Authors

Chemotherapy-induced peripheral neurotoxicity (CIPN) is a major dose-limiting complication of many antineoplastic drugs, including the proteasome inhibitor bortezomib (BTZ). Although traditional in vitro systems help elucidate peripheral neurotoxic mechanisms, their predictive power is constrained by a lack of human-relevant morphological and functional features. To overcome this limitation, neurobiological research is rapidly moving toward human-derived models. A thorough characterization of these systems is crucial to confirm that they faithfully mirror the complex neuro-glial dysfunction seen in clinical CIPN. Here, we performed a comprehensive morpho-functional evaluation of human induced pluripotent stem cell (iPSC)- derived sensory neurons (RealDRG™) and compared them against primary cultured mouse dorsal root ganglion (DRG) neurons upon exposure to different BTZ doses, while also profiling human iPSC-derived Schwann cell precursors (RealSCP™). We employed immunofluorescence to assess marker expression, while label-free holotomography live imaging (Nanolive SA, Tolochenaz, Switzerland) enabled real-time tracking of early neurite alterations and lipid metabolism disarray. This morpho-functional assessment was complemented by multiple assays evaluating proteasome inhibition, cell viability, axonal degeneration, and mitochondrial network analysis. RealDRG™ neurons displayed expression of key markers of peripheral sensory neurons and nociceptors (e.g. TrkA, TrkB, TRPV1, CGRP), while RealSCP™ possessed glial precursor markers like GFAP and S100B. Proteasome inhibition and cell viability assays yielded similar dose/response curves between RealDRG™ and murine neurons. Holotomography and immunofluorescence confirmed early BTZ-induced morphological damage and axonal degeneration across models, complemented with an impaired lipid metabolism highlighted by the pathological accumulation and enlargement of lipid droplets. Moreover, severe mitochondrial network disruption was observed among both RealDRG™ and RealSCP™, consistent with data on murine models, painting a thorough picture of BTZ-induced dysfunction in human neuro-glia. Overall, these findings highlight the translational relevance of human iPSC-derived sensory neurons by aligning them with established models, while our preliminary data on RealSCP™ pave the way for the establishment of a co-culture model that better mimics the human physiological landscape.

Downloads

Download data is not yet available.

Citations

How to Cite



1.
OC26 | MORPHOLOGICAL ALTERATIONS UPON BORTEZOMIB-INDUCED NEUROTOXICITY IN HUMAN IPSC-DERIVED SCHWANN CELL PRECURSOR AND SENSORY NEURON MODELS: F. Iseppon1, E. Tonelli1, A. Malacrida1, V. Rodriguez-Menendez1, M. Santeusanio1, S. Palermo2, D. Cartelli3, A. Scuteri1, C. Meregalli1 | 1School of Medicine and Surgery, Experimental Neurology Unit and Milan Center for Neuroscience, University of Milano-Bicocca, Monza, Italy; 2Department of Biosciences, Università degli Studi di Milano, Italy; 3Neuroalgology Unit, Fondazione IRCCS Istituto Neurologico Carlo Besta, Milan, Italy. Eur J Histochem [Internet]. 2026 Nov. 20 [cited 2026 Nov. 20];70(s2). Available from: https://www.ejh.it/ejh/article/view/4820